arl melanotoan Bio Pharma Frontiers | Role of the
Description
Underappreciated opportunities for low-density lipoprotein management in patients with cardiometabolic residual risk
Shaver M, et al
Tuesday 3 to 5 and 7 to 9 P
Diabetes in day case general and vascular surgery: A multicentre regional audit
Author contributions (I) Conception and design: FZ (II) Administrative support: FZ, FQ, JY (III) Provision of study materials or patients: FZ (IV) Collection and assembly of data: FZ, JY (V) Data analysis and interpretation: FZ, FQ, JY (VI) Manuscript writing: FZ, FQ, JY (VII) Final approval of manuscript: FZ, FQ, JY
7 November 2023
